Table S1 from A Prognostic Model Based on PAM50 and Clinical Variables (PAM50MET) for Metastatic Hormone Receptor–positive HER2-negative Breast Cancer

Authors :: Joel S. Parker
Eva Ciruelos
Stephen Johnston
Vanessa Rodrik-Outmezguine
Jan Christoph Brase
Patricia Galván
Fara Brasó-Maristany
Maria Vidal
Barbara Adamo
Laia Paré
Tomás Pascual
Yi-Hsuan Tsai
Aleix Prat
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Clinical-pathological and genomic variable (n = 21) used to calculate the PAM50MET model. PAM50MET, final model.

Tools